• 中国科学论文统计源期刊
  • 中国科技核心期刊
  • 美国化学文摘(CA)来源期刊
  • 日本科学技术振兴机构数据库(JST)

临床输血与检验 ›› 2026, Vol. 28 ›› Issue (4): 512-517.DOI: 10.3969/j.issn.1671-2587.2026.04.008

• 基础研究 • 上一篇    下一篇

人源化抗Lewis y单克隆抗体Hu3S193对人血小板的体外作用研究*

朱慧君, 何叶, 金筱燕, 朱自严   

  1. 上海市血液中心,上海 200051
  • 收稿日期:2026-07-06 出版日期:2026-08-20 发布日期:2026-08-26
  • 通讯作者: 朱自严,主要从事免疫血液学研究,(E-mail)zhuziyan@sbc.org.cn。
  • 作者简介:朱慧君,主要从事血小板功能方面的研究,(E-mail)zhuhuijun@sbc.org.cn。
  • 基金资助:
    *本课题受国家自然科学基金青年项目(No.82100246)、上海市卫生健康委员会卫生行业临床研究专项(No.202140060)和上海市血液中心科技基金项目(No.L26-5)的资助

The Effect of Humanized Anti-Lewis y Monoclonal Antibody Hu3S193 on Human Platelets in vitro

ZHU Huijun, HE Ye, JIN Xiaoyan, ZHU Ziyan   

  1. Shanghai Blood Center, Shanghai 200051
  • Received:2026-07-06 Online:2026-08-20 Published:2026-08-26

摘要: 目的 Lewis y抗原在多种肿瘤中高表达,人源化单克隆抗体Hu3S193已开展抗肿瘤临床试验。人血小板表面表达Lewis y抗原,但Hu3S193对血小板功能的调控效果尚不明确。本研究探究其对人血小板体外功能的影响,为临床安全用药提供参考。方法 流式细胞术验证Hu3S193与血小板的体外结合;检测P选择素评价α颗粒释放,Fluo-3检测胞内钙离子浓度,分析凝血酶刺激下抗体对血小板活化的影响;血栓弹力图评估凝血功能,流动粘附实验检测对Ⅰ型胶原的粘附能力。结果 Hu3S193可剂量依赖地特异性结合人血小板,高至20 μg/mL不诱导血小板活化,对α颗粒释放及凝血功能最大振幅无明显影响。无凝血酶刺激时,临床剂量Hu3S193可上调胞内钙离子浓度,并以剂量依赖方式抑制对Ⅰ型胶原的流动粘附。结论 Hu3S193不影响人血小板基础活化与凝血功能,但可调控胞内钙离子水平,显著抑制血小板流动粘附功能。

关键词: Lewis y抗原, Hu3S193单克隆抗体, 血小板, 细胞粘附, 凝血功能

Abstract: Objective The blood group-related antigen Lewis y is highly expressed in various tumors, and its humanized monoclonal antibody Hu3S193 has been applied in clinical trials as an anti-tumor drug. Previous studies have confirmed the presence of Lewis y antigen on the surface of human platelets, yet the effect of Hu3S193 on platelet function remains unclear. This study aimed to explore the regulatory effect of Hu3S193 on the in vitro functions of human platelets, providing experimental evidence for the safety and mechanism of its clinical anti-tumor application. Methods Flow cytometry was used to verify the in vitro binding ability of Hu3S193 to human platelets. The release of platelet α-granules was evaluated by detecting P-selectin expression, and the intracellular calcium concentration ([Ca2+]i) of platelets was measured using Fluo-3 fluorescent probe to analyze the effect of Hu3S193 on platelet activation with or without thrombin stimulation. Thromboelastography (TEG) was performed to detect platelet coagulation function, and flow adhesion assay was used to assess the adhesion ability of platelets to type Ⅰ collagen. Results In vitro experiments confirmed that Hu3S193 could specifically bind to human platelets in a concentration-dependent manner. Hu3S193 at clinical dose (5 μg/mL) and higher concentrations (10, 20 μg/mL) had no significant effect on platelet α-granule release and did not induce abnormal platelet activation. TEG detection showed that 5 μg/mL Hu3S193 had no obvious change on maximum amplitude (MA), the core index of platelet coagulation function. In the absence of thrombin stimulation, clinical-dose Hu3S193 significantly increased platelet intracellular calcium concentration and inhibited thrombin-induced calcium influx activation. Flow adhesion experiments verified that Hu3S193 inhibited the flow adhesion ability of platelets to type Ⅰ collagen in a dose-dependent manner. Conclusion Hu3S193 does not affect the basal activation and coagulation function of human platelets. but can regulate platelet intracellular calcium level and significantly inhibit platelet flow adhesion. This finding supplements a new theoretical basis for its anti-tumor mechanism and provides a reference for its clinical safe medication.

Key words: Lewis y antigen, Hu3S193 monoclonal antibody, Platelet, Cell adhesion, Coagulation function

中图分类号: